Instrument Inactif

Autres langues Immunomedics, Inc.

Actions

IMMU

US4529071080

Recherche biotechnologique et médicale

Autres langues

15/12	Immunome jumps after promising results for its desmoid tumor treatment
27/03/23	Everest Medicines Receives Full Upfront Payment from Gilead for Trodelvy-Related Transaction, Boosting Pro Forma Cash Reserves
27/03/23	Everest Medicines Limited announced that it has received $280 million in funding from Immunomedics, Inc.
16/08/22	Gilead to Acquire Remaining Worldwide Rights of Trodelvy
20/04/21	Protara Therapeutics : Announces Appointment of Martin Sebastian Olivo, M.D. as Chief Medical Officer
11/01/21	Gilead Sciences : Raises Product Sales Guidance on Remdesivir Demand, Narrows Earnings Outlook for 2020
11/12/20	Gilead Sciences : Advances Oncology Portfolio with New Data from Phase 3 ASCENT Trial of Trodelvy in Metastatic Triple Negative Breast Cancer
10/12/20	Gilead Sciences : to Pay $1.4 Billion for Hepatitis Drug Maker MYR GmbH of Germany
29/10/20	Gilead Sciences : Announces Third Quarter 2020 Financial Results
29/10/20	Gilead Sciences : Quarterly Revenue Rises on Remdesivir Sales -- Update
28/10/20	Gilead Sciences : Quarterly Revenue Rises on Remdesivir Sales
26/10/20	Gilead Sciences : Completes Acquisition of Immunomedics, Inc.
23/10/20	Immunomedics, Inc. Announces Board Changes
23/10/20	IMMUNOMEDICS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
23/10/20	HBM im Halbjahr 2020/21 mit Gewinnsprung - Zuversichtlich ins zweite Halbjahr
23/10/20	Immunomedics, Inc.(NasdaqGM:IMMU) dropped from S&P Biotechnology Select Industry Index
23/10/20	Immunomedics, Inc.(NasdaqGM:IMMU) dropped from S&P Global BMI Index
23/10/20	Immunomedics, Inc.(NasdaqGM:IMMU) dropped from S&P TMI Index
23/10/20	Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell 1000 Index
23/10/20	Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell Midcap Index
23/10/20	Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell 1000 Growth Index
23/10/20	Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell Midcap Growth Index
23/10/20	Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell 3000 Growth Index
23/10/20	Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell Small Cap Completeness Index
23/10/20	Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell 2500 Growth Index